ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787,897 | +14.4% | 39,277 | +60.8% | 0.00% | – |
| Q2 2023 | $688,888 | +100.0% | 24,420 | +22.0% | 0.00% | – |
| Q1 2023 | $344,378 | +67.0% | 20,022 | +95.5% | 0.00% | – |
| Q4 2022 | $206,213 | -77.6% | 10,239 | -75.9% | 0.00% | – |
| Q3 2022 | $919,000 | +245.5% | 42,406 | +347.8% | 0.00% | – |
| Q2 2022 | $266,000 | -64.0% | 9,470 | -40.8% | 0.00% | – |
| Q1 2022 | $738,000 | -26.2% | 16,000 | +34.6% | 0.00% | – |
| Q4 2021 | $1,000,000 | -43.1% | 11,889 | -64.0% | 0.00% | -100.0% |
| Q2 2021 | $1,756,000 | +79.2% | 33,000 | +74.8% | 0.00% | – |
| Q4 2020 | $980,000 | +57.1% | 18,876 | +45.3% | 0.00% | – |
| Q2 2020 | $624,000 | – | 12,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |